ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Poliomyelitis Vaccine Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-26P2110
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Poliomyelitis Vaccine Market Insights Forecast to 2028
BUY CHAPTERS

Global Poliomyelitis Vaccine Market Research Report 2025

Code: QYRE-Auto-26P2110
Report
January 2025
Pages:84
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
GSK
Sanofi Pasteur
Merck
Crucell
China National Biotech Group
Eli Lilly

Poliomyelitis Vaccine Market Size

The global market for Poliomyelitis Vaccine was valued at US$ 729 million in the year 2024 and is projected to reach a revised size of US$ 852 million by 2031, growing at a CAGR of 2.3% during the forecast period.

Poliomyelitis Vaccine Market

Poliomyelitis Vaccine Market

Polio vaccines are vaccines used to prevent poliomyelitis. There are two types: one that uses inactivated poliovirus and is given by injection, and one that uses weakened poliovirus and is given by mouth.
The World Health Organization recommends all children be fully vaccinated against polio. The two vaccines have eliminated polio from most of the world, and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 37 in 2016.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Poliomyelitis Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Poliomyelitis Vaccine.
The Poliomyelitis Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Poliomyelitis Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Poliomyelitis Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Poliomyelitis Vaccine Market Report

Report Metric Details
Report Name Poliomyelitis Vaccine Market
Accounted market size in year US$ 729 million
Forecasted market size in 2031 US$ 852 million
CAGR 2.3%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • VAPP
  • VDPV
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company GSK, Sanofi-Pasteur, Merck, Crucell, China National Biotech Group, Eli Lilly
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Poliomyelitis Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Poliomyelitis Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Poliomyelitis Vaccine Market growing?

Ans: The Poliomyelitis Vaccine Market witnessing a CAGR of 2.3% during the forecast period 2025-2031.

What is the Poliomyelitis Vaccine Market size in 2031?

Ans: The Poliomyelitis Vaccine Market size in 2031 will be US$ 852 million.

Who are the main players in the Poliomyelitis Vaccine Market report?

Ans: The main players in the Poliomyelitis Vaccine Market are GSK, Sanofi-Pasteur, Merck, Crucell, China National Biotech Group, Eli Lilly

What are the Application segmentation covered in the Poliomyelitis Vaccine Market report?

Ans: The Applications covered in the Poliomyelitis Vaccine Market report are VAPP, VDPV

What are the Type segmentation covered in the Poliomyelitis Vaccine Market report?

Ans: The Types covered in the Poliomyelitis Vaccine Market report are Poliomyelitis Vaccine Ⅰ, Poliomyelitis Vaccine Ⅱ, Poliomyelitis Vaccine Ⅲ, Oral Poliomyelitis Vaccine

Recommended Reports

Human Vaccine Markets

Adjuvants & Delivery Devices

Infectious Disease Vaccines

1 Poliomyelitis Vaccine Market Overview
1.1 Product Definition
1.2 Poliomyelitis Vaccine by Type
1.2.1 Global Poliomyelitis Vaccine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Poliomyelitis Vaccine Ⅰ
1.2.3 Poliomyelitis Vaccine Ⅱ
1.2.4 Poliomyelitis Vaccine Ⅲ
1.2.5 Oral Poliomyelitis Vaccine
1.3 Poliomyelitis Vaccine by Application
1.3.1 Global Poliomyelitis Vaccine Market Value by Application (2024 VS 2031)
1.3.2 VAPP
1.3.3 VDPV
1.4 Global Poliomyelitis Vaccine Market Size Estimates and Forecasts
1.4.1 Global Poliomyelitis Vaccine Revenue 2020-2031
1.4.2 Global Poliomyelitis Vaccine Sales 2020-2031
1.4.3 Global Poliomyelitis Vaccine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Poliomyelitis Vaccine Market Competition by Manufacturers
2.1 Global Poliomyelitis Vaccine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Poliomyelitis Vaccine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Poliomyelitis Vaccine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Poliomyelitis Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Poliomyelitis Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Poliomyelitis Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Poliomyelitis Vaccine, Date of Enter into This Industry
2.8 Global Poliomyelitis Vaccine Market Competitive Situation and Trends
2.8.1 Global Poliomyelitis Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Poliomyelitis Vaccine Players Market Share by Revenue
2.8.3 Global Poliomyelitis Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Poliomyelitis Vaccine Market Scenario by Region
3.1 Global Poliomyelitis Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Poliomyelitis Vaccine Sales by Region: 2020-2031
3.2.1 Global Poliomyelitis Vaccine Sales by Region: 2020-2025
3.2.2 Global Poliomyelitis Vaccine Sales by Region: 2026-2031
3.3 Global Poliomyelitis Vaccine Revenue by Region: 2020-2031
3.3.1 Global Poliomyelitis Vaccine Revenue by Region: 2020-2025
3.3.2 Global Poliomyelitis Vaccine Revenue by Region: 2026-2031
3.4 North America Poliomyelitis Vaccine Market Facts & Figures by Country
3.4.1 North America Poliomyelitis Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Poliomyelitis Vaccine Sales by Country (2020-2031)
3.4.3 North America Poliomyelitis Vaccine Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Poliomyelitis Vaccine Market Facts & Figures by Country
3.5.1 Europe Poliomyelitis Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Poliomyelitis Vaccine Sales by Country (2020-2031)
3.5.3 Europe Poliomyelitis Vaccine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Poliomyelitis Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Poliomyelitis Vaccine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Poliomyelitis Vaccine Sales by Region (2020-2031)
3.6.3 Asia Pacific Poliomyelitis Vaccine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Poliomyelitis Vaccine Market Facts & Figures by Country
3.7.1 Latin America Poliomyelitis Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Poliomyelitis Vaccine Sales by Country (2020-2031)
3.7.3 Latin America Poliomyelitis Vaccine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Poliomyelitis Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Poliomyelitis Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Poliomyelitis Vaccine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Poliomyelitis Vaccine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Poliomyelitis Vaccine Sales by Type (2020-2031)
4.1.1 Global Poliomyelitis Vaccine Sales by Type (2020-2025)
4.1.2 Global Poliomyelitis Vaccine Sales by Type (2026-2031)
4.1.3 Global Poliomyelitis Vaccine Sales Market Share by Type (2020-2031)
4.2 Global Poliomyelitis Vaccine Revenue by Type (2020-2031)
4.2.1 Global Poliomyelitis Vaccine Revenue by Type (2020-2025)
4.2.2 Global Poliomyelitis Vaccine Revenue by Type (2026-2031)
4.2.3 Global Poliomyelitis Vaccine Revenue Market Share by Type (2020-2031)
4.3 Global Poliomyelitis Vaccine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Poliomyelitis Vaccine Sales by Application (2020-2031)
5.1.1 Global Poliomyelitis Vaccine Sales by Application (2020-2025)
5.1.2 Global Poliomyelitis Vaccine Sales by Application (2026-2031)
5.1.3 Global Poliomyelitis Vaccine Sales Market Share by Application (2020-2031)
5.2 Global Poliomyelitis Vaccine Revenue by Application (2020-2031)
5.2.1 Global Poliomyelitis Vaccine Revenue by Application (2020-2025)
5.2.2 Global Poliomyelitis Vaccine Revenue by Application (2026-2031)
5.2.3 Global Poliomyelitis Vaccine Revenue Market Share by Application (2020-2031)
5.3 Global Poliomyelitis Vaccine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Company Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Poliomyelitis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 GSK Poliomyelitis Vaccine Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 Sanofi-Pasteur
6.2.1 Sanofi-Pasteur Company Information
6.2.2 Sanofi-Pasteur Description and Business Overview
6.2.3 Sanofi-Pasteur Poliomyelitis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Sanofi-Pasteur Poliomyelitis Vaccine Product Portfolio
6.2.5 Sanofi-Pasteur Recent Developments/Updates
6.3 Merck
6.3.1 Merck Company Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Poliomyelitis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Merck Poliomyelitis Vaccine Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Crucell
6.4.1 Crucell Company Information
6.4.2 Crucell Description and Business Overview
6.4.3 Crucell Poliomyelitis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Crucell Poliomyelitis Vaccine Product Portfolio
6.4.5 Crucell Recent Developments/Updates
6.5 China National Biotech Group
6.5.1 China National Biotech Group Company Information
6.5.2 China National Biotech Group Description and Business Overview
6.5.3 China National Biotech Group Poliomyelitis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 China National Biotech Group Poliomyelitis Vaccine Product Portfolio
6.5.5 China National Biotech Group Recent Developments/Updates
6.6 Eli Lilly
6.6.1 Eli Lilly Company Information
6.6.2 Eli Lilly Description and Business Overview
6.6.3 Eli Lilly Poliomyelitis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Eli Lilly Poliomyelitis Vaccine Product Portfolio
6.6.5 Eli Lilly Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Poliomyelitis Vaccine Industry Chain Analysis
7.2 Poliomyelitis Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Poliomyelitis Vaccine Production Mode & Process Analysis
7.4 Poliomyelitis Vaccine Sales and Marketing
7.4.1 Poliomyelitis Vaccine Sales Channels
7.4.2 Poliomyelitis Vaccine Distributors
7.5 Poliomyelitis Vaccine Customer Analysis
8 Poliomyelitis Vaccine Market Dynamics
8.1 Poliomyelitis Vaccine Industry Trends
8.2 Poliomyelitis Vaccine Market Drivers
8.3 Poliomyelitis Vaccine Market Challenges
8.4 Poliomyelitis Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
GSK
Sanofi Pasteur
Merck
Crucell
China National Biotech Group
Eli Lilly
List of Tables
 Table 1. Global Poliomyelitis Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Poliomyelitis Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Poliomyelitis Vaccine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Poliomyelitis Vaccine Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Poliomyelitis Vaccine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Poliomyelitis Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Poliomyelitis Vaccine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Poliomyelitis Vaccine Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Poliomyelitis Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Poliomyelitis Vaccine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Poliomyelitis Vaccine, Product Type & Application
 Table 12. Global Key Manufacturers of Poliomyelitis Vaccine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Poliomyelitis Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Poliomyelitis Vaccine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Poliomyelitis Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Poliomyelitis Vaccine Sales by Region (2020-2025) & (K Units)
 Table 18. Global Poliomyelitis Vaccine Sales Market Share by Region (2020-2025)
 Table 19. Global Poliomyelitis Vaccine Sales by Region (2026-2031) & (K Units)
 Table 20. Global Poliomyelitis Vaccine Sales Market Share by Region (2026-2031)
 Table 21. Global Poliomyelitis Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Poliomyelitis Vaccine Revenue Market Share by Region (2020-2025)
 Table 23. Global Poliomyelitis Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Poliomyelitis Vaccine Revenue Market Share by Region (2026-2031)
 Table 25. North America Poliomyelitis Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Poliomyelitis Vaccine Sales by Country (2020-2025) & (K Units)
 Table 27. North America Poliomyelitis Vaccine Sales by Country (2026-2031) & (K Units)
 Table 28. North America Poliomyelitis Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Poliomyelitis Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Poliomyelitis Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Poliomyelitis Vaccine Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Poliomyelitis Vaccine Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Poliomyelitis Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Poliomyelitis Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Poliomyelitis Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Poliomyelitis Vaccine Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Poliomyelitis Vaccine Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Poliomyelitis Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Poliomyelitis Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Poliomyelitis Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Poliomyelitis Vaccine Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Poliomyelitis Vaccine Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Poliomyelitis Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Poliomyelitis Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Poliomyelitis Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Poliomyelitis Vaccine Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Poliomyelitis Vaccine Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Poliomyelitis Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Poliomyelitis Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Poliomyelitis Vaccine Sales (K Units) by Type (2020-2025)
 Table 51. Global Poliomyelitis Vaccine Sales (K Units) by Type (2026-2031)
 Table 52. Global Poliomyelitis Vaccine Sales Market Share by Type (2020-2025)
 Table 53. Global Poliomyelitis Vaccine Sales Market Share by Type (2026-2031)
 Table 54. Global Poliomyelitis Vaccine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Poliomyelitis Vaccine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Poliomyelitis Vaccine Revenue Market Share by Type (2020-2025)
 Table 57. Global Poliomyelitis Vaccine Revenue Market Share by Type (2026-2031)
 Table 58. Global Poliomyelitis Vaccine Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Poliomyelitis Vaccine Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Poliomyelitis Vaccine Sales (K Units) by Application (2020-2025)
 Table 61. Global Poliomyelitis Vaccine Sales (K Units) by Application (2026-2031)
 Table 62. Global Poliomyelitis Vaccine Sales Market Share by Application (2020-2025)
 Table 63. Global Poliomyelitis Vaccine Sales Market Share by Application (2026-2031)
 Table 64. Global Poliomyelitis Vaccine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Poliomyelitis Vaccine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Poliomyelitis Vaccine Revenue Market Share by Application (2020-2025)
 Table 67. Global Poliomyelitis Vaccine Revenue Market Share by Application (2026-2031)
 Table 68. Global Poliomyelitis Vaccine Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Poliomyelitis Vaccine Price (USD/Unit) by Application (2026-2031)
 Table 70. GSK Company Information
 Table 71. GSK Description and Business Overview
 Table 72. GSK Poliomyelitis Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. GSK Poliomyelitis Vaccine Product
 Table 74. GSK Recent Developments/Updates
 Table 75. Sanofi-Pasteur Company Information
 Table 76. Sanofi-Pasteur Description and Business Overview
 Table 77. Sanofi-Pasteur Poliomyelitis Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Sanofi-Pasteur Poliomyelitis Vaccine Product
 Table 79. Sanofi-Pasteur Recent Developments/Updates
 Table 80. Merck Company Information
 Table 81. Merck Description and Business Overview
 Table 82. Merck Poliomyelitis Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Merck Poliomyelitis Vaccine Product
 Table 84. Merck Recent Developments/Updates
 Table 85. Crucell Company Information
 Table 86. Crucell Description and Business Overview
 Table 87. Crucell Poliomyelitis Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Crucell Poliomyelitis Vaccine Product
 Table 89. Crucell Recent Developments/Updates
 Table 90. China National Biotech Group Company Information
 Table 91. China National Biotech Group Description and Business Overview
 Table 92. China National Biotech Group Poliomyelitis Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. China National Biotech Group Poliomyelitis Vaccine Product
 Table 94. China National Biotech Group Recent Developments/Updates
 Table 95. Eli Lilly Company Information
 Table 96. Eli Lilly Description and Business Overview
 Table 97. Eli Lilly Poliomyelitis Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Eli Lilly Poliomyelitis Vaccine Product
 Table 99. Eli Lilly Recent Developments/Updates
 Table 100. Key Raw Materials Lists
 Table 101. Raw Materials Key Suppliers Lists
 Table 102. Poliomyelitis Vaccine Distributors List
 Table 103. Poliomyelitis Vaccine Customers List
 Table 104. Poliomyelitis Vaccine Market Trends
 Table 105. Poliomyelitis Vaccine Market Drivers
 Table 106. Poliomyelitis Vaccine Market Challenges
 Table 107. Poliomyelitis Vaccine Market Restraints
 Table 108. Research Programs/Design for This Report
 Table 109. Key Data Information from Secondary Sources
 Table 110. Key Data Information from Primary Sources
 Table 111. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Poliomyelitis Vaccine
 Figure 2. Global Poliomyelitis Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Poliomyelitis Vaccine Market Share by Type: 2024 & 2031
 Figure 4. Poliomyelitis Vaccine Ⅰ Product Picture
 Figure 5. Poliomyelitis Vaccine Ⅱ Product Picture
 Figure 6. Poliomyelitis Vaccine Ⅲ Product Picture
 Figure 7. Oral Poliomyelitis Vaccine Product Picture
 Figure 8. Global Poliomyelitis Vaccine Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Poliomyelitis Vaccine Market Share by Application: 2024 & 2031
 Figure 10. VAPP
 Figure 11. VDPV
 Figure 12. Global Poliomyelitis Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Poliomyelitis Vaccine Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Poliomyelitis Vaccine Sales (2020-2031) & (K Units)
 Figure 15. Global Poliomyelitis Vaccine Average Price (USD/Unit) & (2020-2031)
 Figure 16. Poliomyelitis Vaccine Report Years Considered
 Figure 17. Poliomyelitis Vaccine Sales Share by Manufacturers in 2024
 Figure 18. Global Poliomyelitis Vaccine Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Poliomyelitis Vaccine Players: Market Share by Revenue in Poliomyelitis Vaccine in 2024
 Figure 20. Poliomyelitis Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Poliomyelitis Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Poliomyelitis Vaccine Sales Market Share by Country (2020-2031)
 Figure 23. North America Poliomyelitis Vaccine Revenue Market Share by Country (2020-2031)
 Figure 24. U.S. Poliomyelitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Poliomyelitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Poliomyelitis Vaccine Sales Market Share by Country (2020-2031)
 Figure 27. Europe Poliomyelitis Vaccine Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Poliomyelitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Poliomyelitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Poliomyelitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Poliomyelitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Poliomyelitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Poliomyelitis Vaccine Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Poliomyelitis Vaccine Revenue Market Share by Region (2020-2031)
 Figure 35. China Poliomyelitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Poliomyelitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Poliomyelitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Poliomyelitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Poliomyelitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Taiwan Poliomyelitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Poliomyelitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Poliomyelitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Poliomyelitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Philippines Poliomyelitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Poliomyelitis Vaccine Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Poliomyelitis Vaccine Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Poliomyelitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Poliomyelitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Poliomyelitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Poliomyelitis Vaccine Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Poliomyelitis Vaccine Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Poliomyelitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Poliomyelitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. U.A.E Poliomyelitis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Poliomyelitis Vaccine by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Poliomyelitis Vaccine by Type (2020-2031)
 Figure 57. Global Poliomyelitis Vaccine Price (USD/Unit) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Poliomyelitis Vaccine by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Poliomyelitis Vaccine by Application (2020-2031)
 Figure 60. Global Poliomyelitis Vaccine Price (USD/Unit) by Application (2020-2031)
 Figure 61. Poliomyelitis Vaccine Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Global Polio Vaccination Market Research Report 2025
Poliovirus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Polio Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Poliomycetes Vaccine Market Insights Forecast to 2030
Global Combined Polio Vaccine Market Research Report 2024
Inactivated Poliovirus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Inactivated Polio Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Poliovirus Vaccine Inactivated Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Live Attenuated Polio Vaccine Market Research Report 2024
Global Inactivated Polio Virus Vaccine Market Research Report 2025
Global Poliomyelitis Vaccine in Dragee Candy Market Research Report 2025
Global Pneumococcal Vaccination Market Research Report 2025
Pneumococcal Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
Global Poliomyelitis Therapeutics Market Insights Forecast to 2030
Veterinary Vaccine Market
Inactivated Polio and Rabies Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Viral Vector Vaccine for Humans Market Research Report 2024
Global Veterinary Vaccination Market Research Report 2025
Global Sabin Inactivated Polio vaccine sIPV Market Research Report 2025
Global Measle Vaccine Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions